SEARCH

SEARCH BY CITATION

References

  • 1
    Community Preventive Services Task Force. Guide to Community-Preventive Services—Cardiovascular Disease Prevention and Control: Team-Based Care to Improve Blood Pressure Control. Atlanta, GA: US Department of Health and Human Services, CDC; 2012. http://www.thecommunityguide.org/cvd/teambasedcare.html. Accessed March 1, 2014.
  • 2
    Valderama AL, Gillespie CG, Coleman KS, et al. Vital signs: awareness and treatment of uncontrolled hypertension among adults – United States, 2003–2010. MMWR Morb Mortal Wkly Rep. 2012;61:703710.
  • 3
    Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:25602571.
  • 4
    Roger V, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 2012;125:e2e220.
  • 5
    Heidenreich PA, Trogdon JG, Khajou OA, et al. Forecasting the future of cardiovascular disease in the United States. A policy statement from the American Heart Association. Circulation. 2011;123:933944.
  • 6
    Lloyd-Jones D, Adams RJ, Brown T M, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2009;121:e46e215.
  • 7
    Freiden TR, Berwick DM. The “million hearts” initiative—preventing heart attacks and strokes. N Engl J Med. 2011;365:e27.
  • 8
    Zerhouni E. The NIH roadmap. Science. 2003;302:6364.
  • 9
    NIH Roadmap: Reengineering the Clinical Research Enterprise Regional Translational Research Centers Interim Report http://commonfund.nih.gove/pdf/rtrc_interimreport.pdf 2004. Accessed March 1, 2014.
  • 10
    Zerhouni E. US biomedical research: basic, translational, and clinical sciences. JAMA. 2005;294:13521358.
  • 11
    Zerhounit E Translational and clinical science—time for a new vision. N Engl J Med. 2005;335:16211623.
  • 12
    Egan BM, Lackland DT, Basile JN. American Society of Hypertension regional chapters: leveraging the impact of the clinical hypertension specialist in the local community. Am J Hypertens. 2002;15:372379.
  • 13
    Egan BM, Lackland DT, Igho-Pemu P, et al. Cardiovascular risk factor control in communities—update from the ASH Carolinas-Georgia chapter, the hypertension initiative, and the community physicians' network. J Clin Hypertens (Greenwich). 2006;8:879886.
  • 14
    Green LA, Hickner J. A short history of primary care practice-based research networks: from concept to essential research laboratories. J Am Board Fam Med. 2006;19:110.
  • 15
    Mold JW, Peterson K. A primary care practice-based research networks: working at the interface between research and quality improvement. Ann Fam Med. 2005;3:S12S20.
  • 16
    Solberg LI. Recruiting medical groups for research: relationships, reputation, requirements, rewards, reciprocity, resolution and respect. Implement Sci. 2006;1:17.
  • 17
    Egan BM, Laken MA, Wagner CS, et al. Impacting population cardiovascular health through a community-based practice network: update on an ASH-supported collaborative. J Clin Hypertens (Greenwich). 2011;13:543550.
  • 18
    Fagnan LJ, Morris C, Shipman SC, et al. Characterizing a practice-based research network: Oregon rural practice-based research network (OPRPN) survey tools. J Am Board Fam Med. 2007;20:204219.
  • 19
    Graham DG, Spano MS, Stewart TV, et al. Strategies for planning and launching PBRN research studies: a project of the academy of family physicians national research networks (AAFP NRN). J Am Board Fam Med. 2007;20:220228.
  • 20
    Bakken S, Lantigua RA, Busacca LV, Biggers JT. Barriers, enablers, and incentives for research participation: a report from the Ambulatory Care Research Network (ACRN). J Am Board Fam Med. 2009;22:436445.
  • 21
    Conway PH, Clancy C. Transformation of health care at the front line. JAMA. 2009;301:763765.
  • 22
    Nembhard IM, Alexander JA, Hoff TJ, Ramanujam R. Why does the quality of health care continue to lag? Insights from management research. Acad Manag Perspect. 2009:2442..
  • 23
    Fagnan LJ, Davis M, Deyo RA, et al. Linking practice-based research networks and clinical and translational science awards: new opportunities for community engagement by academic health centers. Acad Med. 2010;85:476483.
  • 24
    Gibson K, Szilagyi P, Swanger CM, et al. Physician perspectives on incentives to participate in practice-based research: a Greater Rochester Practice-Based Research Network (GR-PBRN) study. J Am Board Fam Med. 2010;23:452454.
  • 25
    Allaire BT, Trogdon JG, Egan BM, et al. Measuring the impact of a continuing medical education program on patient blood pressure J Clin Hypertens (Greenwich). 2011;13:517522.
  • 26
    Egan BM, Zhao Y, Axon RN US trends in prevalence, awareness, treatment and control of hypertension, 1998–2008 JAMA. 2010;303:20432050.
  • 27
    Centers for Disease Control and Prevention. Million Hearts Initiative. Available at: http://millionheartshhsgov/about_mhhtml Accessed June 13, 2013.
  • 28
    Wisconsin Department of Health Services Behavioral Risk Factor Surveillance SurveySystem Available at: http://wwwdhswisconsingov/stats/BRFShtm Accessed June 13, 2013.
  • 29
    Hall WD, Ferrario CM, Moore MA, et al. Hypertension-related morbidity and mortality in the southeastern United States Am J Med Sci. 1997;313:195209.
  • 30
    Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the national health and nutrition examination survey, 1999 to 2000. Circulation. 2003;107:21852189.
  • 31
    Hajjar H, Kotchen TA. Trends in prevalence, awareness, treatment and control of hypertension in the United States, 1988–2000. JAMA. 2003;290:199206.
  • 32
    Egan BM, Laken MA. Is BP control to <140/<90 mm Hg in 50% of all hypertensive patients as good as we can do in the United States? Or is this as good as it gets? Curr Opin Cardiol. 2011;26:356361.
  • 33
    Okonofua EC, Simpson KN, Jesri A, et al. Therapeutic inertia is an impediment to achieving the healthy people 2010 blood pressure control goals. Hypertension. 2006;47:345351.
  • 34
    Davis BR, Cutler JA, Gordon DJ, et al. Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). Am J Hypertens. 1996;9:342360.
  • 35
    Wisconsin Department of Health Services Heart Disease and Stroke Prevention Program. Available at: http://wwwdhswisconsingov/health/cardiovascular/. Accessed May 6, 2013.